Canada Pension Plan Investment Board
MRTX

Canada Pension Plan Investment Board’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,300
Closed -$606K – 1125
2023
Q1 		$606K Buy
16,300
+14,216
+682% +$639K ﹤0.01% 950
2022
Q4 		$94.4K Buy
+2,084
New +$135K ﹤0.01% 1031
2022
Q1 		– Sell
-49,000
Closed -$7.19M – 1626
2021
Q4 		$7.19M Buy
+49,000
New +$7.61M 0.01% 640
2021
Q3 		– Sell
-246
Closed -$40K – 1488
2021
Q2 		$40K Sell
246
-1,937
-89% -$311K ﹤0.01% 1078
2021
Q1 		$374K Buy
2,183
+1,903
+680% +$377K ﹤0.01% 1092
2020
Q4 		$61K Buy
+280
New +$60.5K ﹤0.01% 1271
2020
Q2 		– Sell
-2,211
Closed -$170K – 1497
2020
Q1 		$170K Buy
2,211
+2,181
+7,270% +$196K ﹤0.01% 1127
2019
Q4 		$4K Buy
+30
New +$2.89K ﹤0.01% 1390

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Canada Pension Plan Investment Board's MRTX Position: Q2 2023 in Review

Canada Pension Plan Investment Board sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 16,300 shares — an estimated $606K sold.

Canada Pension Plan Investment Board first reported a position in MRTX in Q4 2019 and held it in 8 quarters. The position peaked at $7.19M in Q4 2021. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

  • Canada Pension Plan Investment Board reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 16,300 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $606K.
  • Canada Pension Plan Investment Board first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Mirati Therapeutics, Inc. Common Stock position peaked at $7.19M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2023, filed 9 Aug 2023.